发明名称 Pharmaceutical suspension composition
摘要 An aqueous oral liquid pharmaceutical composition system with reduced propensity for agglomeration and phase separation which is particularly amendable to the suspension of one or more pharmaceutical actives that are substantially insoluble in water. The oral liquid pharmaceutical composition may further comprise pharmaceutical actives that are soluble in water and dissolve in the aqueous medium. In the composition of the invention both suspended and any dissolved active agents are distributed homogeneously.
申请公布号 ZA200504239(B) 申请公布日期 2007.02.28
申请号 ZA20050004239 申请日期 2005.05.24
申请人 WYETH 发明人 DICKERSON, JAY;TRIMMER, ANNABELLE;ALLEY, AMANDA ROOP;MARK, WILLIAM;JAEGER, DAVID
分类号 A61K;A61K9/00;A61K9/10;A61K9/14;A61K9/66;A61K47/10;A61K47/26;A61P 主分类号 A61K
代理机构 代理人
主权项
地址